138 related articles for article (PubMed ID: 2578509)
1. Lymphoma models for B cell activation and tolerance. I. Conditions for the anti-mu-dependent stimulation of growth in NBL, a nude B cell lymphoma.
Ling M; Livnat D; Pillai PS; Scott DW
J Immunol; 1985 Mar; 134(3):1449-54. PubMed ID: 2578509
[TBL] [Abstract][Full Text] [Related]
2. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
Udhayakumar V; Kumar L; Subbarao B
J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
[TBL] [Abstract][Full Text] [Related]
3. IL-4 (B cell stimulatory factor 1) overcomes Fc gamma receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction.
Phillips NE; Gravel KA; Tumas K; Parker DC
J Immunol; 1988 Dec; 141(12):4243-9. PubMed ID: 2974056
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
[TBL] [Abstract][Full Text] [Related]
5. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis.
Phillips NE; Parker DC
J Immunol; 1984 Feb; 132(2):627-32. PubMed ID: 6228594
[TBL] [Abstract][Full Text] [Related]
6. Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells.
Pennell CA; Scott DW
Eur J Immunol; 1986 Dec; 16(12):1577-81. PubMed ID: 3493148
[TBL] [Abstract][Full Text] [Related]
7. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
Baluyut AR; Subbarao B
J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924
[TBL] [Abstract][Full Text] [Related]
8. B cells from M167 mu kappa transgenic mice fail to proliferate after stimulation with soluble anti-Ig antibodies. A model for antigen-induced B cell anergy.
Sieckmann DG; Holmes K; Hornbeck P; Martin E; Guelde G; Bondada S; Longo DL; Kenny JJ
J Immunol; 1994 May; 152(10):4873-83. PubMed ID: 8176209
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
Yamashita T; Koyama J
J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
[TBL] [Abstract][Full Text] [Related]
10. Functional studies on B cell hybridomas with B cell surface antigens. I. Effects of anti-immunoglobulin antibodies on proliferation and differentiation.
Hamano T; Asofsky R
J Immunol; 1983 May; 130(5):2027-32. PubMed ID: 6403617
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines.
Scott DW; O'Garra A; Warren D; Klaus GG
J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte function-associated antigen (LFA-1) is involved in B cell activation.
Howard DR; Eaves AC; Takei F
J Immunol; 1986 Jun; 136(11):4013-8. PubMed ID: 2422269
[TBL] [Abstract][Full Text] [Related]
13. Regulation of an idiotype+ B cell lymphoma. Effects of antigen and anti-idiotopic antibodies on proliferation and Ig secretion.
Ward RE; McNamara-Ward M; Webb CF; Altman D; Lim PL; Tucker PW; Kohler H
J Immunol; 1988 Jul; 141(1):340-6. PubMed ID: 3259969
[TBL] [Abstract][Full Text] [Related]
14. Effects of mu-specific antibodies on B cell growth and maturation.
Leanderson T; Forni L
Eur J Immunol; 1984 Nov; 14(11):1016-21. PubMed ID: 6437843
[TBL] [Abstract][Full Text] [Related]
15. Growth regulation of the B lymphoma cell line WEHI-231 by anti-immunoglobulin, lipopolysaccharide, and other bacterial products.
Jakway JP; Usinger WR; Gold MR; Mishell RI; DeFranco AL
J Immunol; 1986 Oct; 137(7):2225-31. PubMed ID: 3489760
[TBL] [Abstract][Full Text] [Related]
16. Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells.
Page DM; DeFranco AL
J Immunol; 1988 Jun; 140(11):3717-26. PubMed ID: 2836499
[TBL] [Abstract][Full Text] [Related]
17. Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics.
George AJ; Spellerberg MB; Stevenson FK
J Immunol; 1988 Mar; 140(5):1695-701. PubMed ID: 3162250
[TBL] [Abstract][Full Text] [Related]
18. Expression, distribution and specificity of Fc receptors for IgM on murine B cells.
Mathur A; Lynch RG; Köhler G
J Immunol; 1988 Sep; 141(6):1855-62. PubMed ID: 2971716
[TBL] [Abstract][Full Text] [Related]
19. The expression of membrane and secreted immunoglobulin during the in vitro differentiation of the murine B cell lymphoma CH12.
Stockdale AM; Dul JL; Wiest DL; Digel M; Argon Y
J Immunol; 1987 Nov; 139(10):3527-35. PubMed ID: 3500220
[TBL] [Abstract][Full Text] [Related]
20. Proliferation of human malignant lymphocytes induced by anti-IgM independent of B cell growth factor.
Baeker TR; Rothstein TL
J Immunol; 1985 May; 134(5):3532-8. PubMed ID: 3872333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
